Grants and Contributions:
Title:
Development of off-the-shelf TAC T cells
Agreement Number:
914154
Agreement Value:
$74,900.00
Agreement Date:
Nov 5, 2018 - Nov 1, 2019
Description:
Triumvira Immunologics has developed a potent new personalized cell therapy for cancer. The personalized nature of the product is a major driver of cost and can delay patient access. In this project, Triumvira will work to develop an off-the-shelf solution, which should lower cost and improve patient access.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Hamilton, Ontario, CA L8P 0A1
Reference Number:
172-2018-2019-Q4-914154
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
821677523
Recipient Type:
For-profit organization
Recipient's Legal Name:
Triumvira Immunologics Inc.
Federal Riding Name:
Hamilton Centre
Federal Riding Number:
35035
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410